Opinion
Video
Author(s):
Medical experts open a discussion providing an update on the current impact of metastatic colorectal cancer and common treatment strategies.
ctDNA Generates Momentum in Adjuvant Stage II/III Colon Cancer Setting
Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
Telisotuzumab Adizutecan Delivers Early Signals of Antitumor Activity in CRC
Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC
Accurate Diagnosis of dMMR/MSI-H Status Is Key for Nivolumab/Ipilimumab Treatment in mCRC
Treatment Personalization Is Poised to Define New Era of mCRC Therapy
RVU120 Shows Early Promise in R/R Metastatic or Advanced Solid Tumors
The WEE1 Inhibitor APR-1051 Shows Early Safety and Tolerability in Advanced, Mutated Solid Tumors
TYRA-300 Is Safe, Generates Preliminary Antitumor Activity in FGFR3+ Metastatic Urothelial Cancer
Experts Highlight Noteworthy Research From the 2024 ESMO Congress